Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Aringer

Showing results (201-210 of 217) with videos related to

Pageof 22
Sort By:
Nature Genetics|March 11, 2008
SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and goutVeronique Vitart, Igor Rudan, Caroline Hayward, et al.
Annals of the Rheumatic Diseases|May 14, 2015
Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task forceJosef S Smolen, Ferdinand C Breedveld, Gerd R Burmester, et al.
The Journal of Clinical Investigation|December 16, 2014
Defective removal of ribonucleotides from DNA promotes systemic autoimmunityClaudia Günther, Barbara Kind, Martin A M Reijns, et al.
Respiration; International Review of Thoracic Diseases|February 5, 2026
Sex-specific phenotypes and outcomes in non‑IPF interstitial lung disease: results from the INSIGHTS‑ILD registryDirk Koschel, Francesco Bonella, Andreas Günther, et al.
Annals of the Rheumatic Diseases|October 12, 2023
EULAR recommendations for the management of systemic lupus erythematosus: 2023 updateAntonis Fanouriakis, Myrto Kostopoulou, Jeanette Andersen, et al.
Annals of the Rheumatic Diseases|March 8, 2017
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 updateJosef S Smolen, Robert Landewé, Johannes Bijlsma, et al.
Arthritis Research & Therapy|May 17, 2011
Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID)Hans-Peter Tony, Gerd Burmester, Hendrik Schulze-Koops, et al.
Annals of the Rheumatic Diseases|November 26, 2016
A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)Ronald van Vollenhoven, Alexandre Voskuyl, George Bertsias, et al.
Annals of the Rheumatic Diseases|January 24, 2020
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 updateJosef S Smolen, Robert B M Landewé, Johannes W J Bijlsma, et al.
Seminars in Arthritis and Rheumatism|August 6, 2024
OMERACT systemic lupus erythematosus domain surveyWils Nielsen, Vibeke Strand, Lee Simon, et al.
Pageof 22

Showing results (201-210 of 217) with videos related to

Sort By:
Pageof 22
Nature Genetics|March 11, 2008
SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and goutVeronique Vitart, Igor Rudan, Caroline Hayward, et al.
Annals of the Rheumatic Diseases|May 14, 2015
Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task forceJosef S Smolen, Ferdinand C Breedveld, Gerd R Burmester, et al.
The Journal of Clinical Investigation|December 16, 2014
Defective removal of ribonucleotides from DNA promotes systemic autoimmunityClaudia Günther, Barbara Kind, Martin A M Reijns, et al.
Respiration; International Review of Thoracic Diseases|February 5, 2026
Sex-specific phenotypes and outcomes in non‑IPF interstitial lung disease: results from the INSIGHTS‑ILD registryDirk Koschel, Francesco Bonella, Andreas Günther, et al.
Annals of the Rheumatic Diseases|October 12, 2023
EULAR recommendations for the management of systemic lupus erythematosus: 2023 updateAntonis Fanouriakis, Myrto Kostopoulou, Jeanette Andersen, et al.
Annals of the Rheumatic Diseases|March 8, 2017
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 updateJosef S Smolen, Robert Landewé, Johannes Bijlsma, et al.
Arthritis Research & Therapy|May 17, 2011
Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID)Hans-Peter Tony, Gerd Burmester, Hendrik Schulze-Koops, et al.
Annals of the Rheumatic Diseases|November 26, 2016
A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)Ronald van Vollenhoven, Alexandre Voskuyl, George Bertsias, et al.
Annals of the Rheumatic Diseases|January 24, 2020
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 updateJosef S Smolen, Robert B M Landewé, Johannes W J Bijlsma, et al.
Seminars in Arthritis and Rheumatism|August 6, 2024
OMERACT systemic lupus erythematosus domain surveyWils Nielsen, Vibeke Strand, Lee Simon, et al.
Pageof 22